CA Patent

CA2948148C — Formulations of cyclophosphamide liquid concentrate

Assigned to Auromedics Pharma LLC · Expires 2022-12-06 · 3y expired

What this patent protects

Cyclophosphamide containing compositions preferably in the form of solutions having extended stability are disclosed. The compositions contain cyclophosphamide, ethanol and an ethanol soluble acidifying agent such as citric acid. Ready to dilute or ready to use cyclophosphamide c…

USPTO Abstract

Cyclophosphamide containing compositions preferably in the form of solutions having extended stability are disclosed. The compositions contain cyclophosphamide, ethanol and an ethanol soluble acidifying agent such as citric acid. Ready to dilute or ready to use cyclophosphamide containing composition of the invention maintain high levels cyclophosphamide content after about 18 or 24 months at a temperature of about 5°C.

Drugs covered by this patent

Patent Metadata

Patent number
CA2948148C
Jurisdiction
CA
Classification
—
Expires
2022-12-06
Drug substance claim
No
Drug product claim
No
Assignee
Auromedics Pharma LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.